NPC - AXEL Study : Axitinib-Avelumab

Clinical trial NCT04562441 · COMPLETED

Trial details

NCT number: NCT04562441
Sponsor: Chinese University of Hong Kong
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic NPC

Start date: 2021-05-06
Primary completion: 2024-10-31
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.